Chronic liver disease causes high morbidity and mortality worldwide. In addition, the World Health Organization ascribed in 2004 a disability-adjusted life year (DALY) estimate of 37,760 years lost due to ill health, disability or early death per 100,000 individuals suffering from chronic liver disease 1 . The only cure for end-stage liver disease is liver transplantation; however, donor organ availability cannot meet demand, and many patients die 2 . For this reason, it is necessary to understand the mechanisms controlling regeneration in chronic liver disease and to identify pathways for liver regeneration that could be therapeutically targeted. This is feasible because the liver provides a unique model of solid organ regeneration with a proven contribution from HPCs 3, 4 . In human disease, HPCs form a central component of the ductular reaction, which expands in an activated niche to regenerate the damaged liver 4, 5 . Injury and regeneration are often described separately as discrete events; however, the importance of the inflammatory response in cellular regeneration has been highlighted in several organs, linking inflammation with both scar formation and restoration of a functional epithelium [6] [7] [8] .
During ontogeny, the Notch and Wnt signaling pathways have been implicated in the lineage specification of cholangiocytes and hepatocytes, respectively [9] [10] [11] . The Notch pathway is necessary for specification of the biliary tree, and Notch pathway ablation results in failure of hepatoblast specification into cholangiocytes 12, 13 , resulting in bile duct paucity, a characteristic of Alagilles syndrome [13] [14] [15] [16] . Furthermore, ectopic activation of the Notch pathway in fetal hepatoblasts by overexpression of the Notch intracellular domain (NICD) results in hyperarborization of biliary ductules 17 .
The Notch pathway comprises a family of single-span receptors, as well as the ligand families Jagged and Delta 18 . Receptor-ligand interactions result in the liberation of the NICD, which forms a heteromeric transcriptional complex, and induces expression of Hes and Hey, which act as transcriptional repressors 19 . Wnt ligands, on the other hand, bind LRP-Frizzled receptors, resulting in sequestration of the APC-GSK-CK1 complex to the cell membrane which, when not sequestered, acts to phosphorylate Ctnnb1 protein (also known as β-catenin, a central mediator of Wnt-driven transcriptional activation) and targets the Ctnnb1 protein for degradation. Stable Ctnnb1, however, is free to translocate to the cell nucleus where it binds Lef and Tcf transcription factors on enhancer elements of target genes [20] [21] [22] . Numb, which encodes the ubiquitin ligase Numb, is a direct transcriptional target of the Wnt signaling pathway, and Notch signaling is modified by Numb, which acts as a negative regulator of the Notch signaling pathway [23] [24] [25] . Therefore, Numb represents a node at which the Notch and Wnt pathways can converge and interact during cell fate determination 26, 27 .
In ductular reactions of chronic human disease, we sought to define Notch and Wnt signaling during lineage specification and have studied two disease patterns where ductular reactions form and human HPCs (hHPCs) are activated. We studied tissue from patients with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) when investigating biliary repair and tissue from those with hepatitis C virus (HCV) infection to investigate the mechanisms of hepatocellular regeneration. We modeled these disease states using mouse dietary regimes in which an activated mouse HPC (mHPC) niche forms and the mHPCs contribute to regeneration of hepatocytes and biliary epithelia 3, 28 . Specifically, we used the choline-deficient, ethionine-supplemented (CDE) 29, 30 regime to model hepatocellular regeneration or the 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) 31, 32 regime to model biliary regeneration.
RESULTS
Spatial variability in the HPC niche HPC-mediated liver regeneration is characterized by the establishment of a stereotypical inflammatory niche that forms around emerging HPCs 33 . This activated HPC niche, which constitutes the ductular reaction in human disease and mouse models, consists principally of macrophages and myofibroblasts and requires the de novo synthesis of an extracellular matrix (ECM) to facilitate appropriate HPC expansion 29 (Fig. 1a) . Using mouse models of both biliary and hepatocyte regeneration, we digitally reconstructed the activated mHPC niche in three dimensions. We histochemically stained serial sections for cell-specific antigens to distinguish macrophages (F4/80), myofibroblasts (α-smooth muscle actin (α-SMA)) and HPCs (the basophilic cytokeratins CK7 and CK19 (panCK)). We also stained for collagen I, from which we digitally reconstructed and assessed niche formation in these different regenerative contexts.
During biliary regeneration, the activated mHPCs were surrounded by a thick layer of α-SMA-positive myofibroblasts, which constituted the bulk of the activated ductular reaction (Fig. 1b) . These myofibroblasts formed close associations with the emerging mHPCs and, therefore, were capable of influencing the mHPCs. Myofibroblasts were intimately associated with collagen I, which was deposited as a thick sheath around the ductular reaction ( Fig. 1c) and which excluded macrophages from forming close associations with the mHPCs throughout biliary regeneration. Therefore, we hypothesized that the macrophages were incapable of influencing mHPCs during this aspect of the ductal reaction. During hepatocyte regeneration the mHPC niche consisted predominantly of macrophages and was more diffuse, with fewer myofibroblasts and reduced collagen I, allowing macrophages to associate closely with mHPCs ( Fig. 1b,c) .
Notch is involved in biliary regeneration
In both human biliary and hepatocellular diseases, NOTCH1 and NOTCH2 were highly expressed in CK7-positive hHPCs isolated with laser-capture microdissection ( Fig. 2a) . NOTCH2 protein was found predominantly within the membrane and cytoplasm of hHPCs within the ductular reaction during hepatocyte regeneration ( Fig. 2a) . In contrast, during biliary regeneration, NOTCH2 protein was frequently localized to the cytoplasm and nucleus of hHPCs, suggesting Notch pathway activation ( Fig. 2a) . We confirmed the activation of the Notch pathway in end-stage biliary disease and regeneration by analyzing the HES and HEY family of Notch targets. In biliary regeneration we saw high mRNA expression of both Notch targets HES1 and HEY1 in hHPCs ( Fig. 2a ) compared with hHPCs isolated during hepatocyte regeneration, implying that in hepatocyte regeneration there was restricted activation of the Notch pathway. In both human disease patterns, the Notch receptors were highly expressed; however, the Notch pathway ligand JAGGED1 was modulated and more highly expressed in the ductular reaction during biliary regeneration than during hepatocyte regeneration. JAGGED1 protein consistently localized to the hHPC cell surface in PBC and PSC ( Fig. 2a) , indicating active Notch signaling during biliary regeneration.
To investigate the mechanisms underpinning these observations in humans, we used mouse models of mHPC-derived hepatocellular and biliary regeneration. Mouse HPCs were isolated by size and positive staining for epithelial cell adhesion molecule (EpCAM), which is npg expressed in the mHPC population in both biliary and hepatocellular disease patterns. In sorted mHPCs, Notch1 and Notch2 are highly expressed during biliary regeneration, compared with mHPCs isolated during hepatocellular regeneration ( Fig. 2b) . Furthermore, the Notch pathway effectors encoded by Hes5 and Heyl are more highly expressed in mHPCs during biliary regeneration than during hepatocyte regeneration ( Fig. 2b) . Activation of the Notch signaling pathway was confirmed though visualization of cleaved Notch1 in the nucleus of mHPCs during biliary regeneration but was rarely seen in hepatocellular regeneration ( Fig. 2b) , indicating that these disease models appropriately reproduce the human Notch pathway paradigm. In mouse biliary injury, Jagged1 ligand was expressed by mHPCassociated myofibroblasts, whereas, in hepatocellular injury, Jagged1 was not detectable in mHPC-associated myofibroblasts (Fig. 2b) .
Notch inhibition results in failure of biliary specification
We isolated mHPCs from mice with hepatocyte injury and cocultured them with Jagged1-positive myofibroblasts (Supplementary Fig. 1a ). This induced Notch pathway activation, which was confirmed by the induction of Hes1, Hes5, Hey1 and Heyl mRNA expression, which reflected the Notch-high state of high Hes1 and Hey1 expression described for biliary regeneration in humans ( Supplementary Fig. 1a ).
These cocultures were treated either with N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT), a γ-secretase inhibitor, or with vehicle alone. Inhibition of γ-secretase resulted in significantly lower expression of Notch effectors encoded by Hes1, Hes5, Hey1 and Heyl (Fig. 2c) . The lower Hes and Hey mRNA expression was associated with lower mRNA expression of both the early transcription factor Hnf1b and the mature biliary proteins Hnf6 and Ggt (Fig. 2c) .
Our in vitro data showed that Notch signaling was required for the specification of HPCs into bile ducts. To show a functional role for Notch in vivo, we blocked Notch receptor cleavage in vivo using DAPT as previously described 34, 35 . After 2 weeks of biliary damage, mice received intravenous DAPT or control solution for the final 5 d of injury. Inhibition of γ-secretase resulted in a lower number of mHPCs ( Fig. 2d) . Isolated mHPCs from DAPT-treated mice showed lower expression of the Notch pathway effectors Hes1 and Hes5 versus HPCs from vehicletreated control livers. Furthermore, Hnf1b and Hnf6, encoded by genes associated with biliary cell phenotype, showed lower expression ( Fig. 2e) . Inhibition of γ-secretase caused no change in the amounts of the hepatocyte transcription factor Hnf4a ( Fig. 2e ), suggesting that Notch signaling was not involved in hepatocyte regeneration. To confirm this, we gave intravenous DAPT to mice undergoing 2 weeks of mHPC-mediated hepatocyte regeneration and found no marked difference in the number of mHPCs versus controls. Moreover, isolated mHPCs showed no change in expression in early liver-enriched transcription factors Hnf1b, Hnf6 and Hnf4a versus HPCs from vehicle-treated control livers ( Supplementary Fig. 1b) . DAPT had no effect upon the niche composition or fibrosis, indicating that loss of mHPCs was probably due to a differentiation defect rather than a failure of mHPC maintenance by the surrounding activated niche (Supplementary Fig. 2a-c) .
Numb facilitates hepatocyte differentiation
Notch receptor is present in the ductular reactions of both human disease patterns and during mouse biliary regeneration ( Fig. 2a,b) , and we hypothesized that there was a second tier of Notch receptor inhibition. An elevated expression of NUMB has been observed in HCV samples compared with PBC and PSC samples 36 npg the underlying factors that regulate Notch during hepatocellular and biliary regeneration, we characterized NUMB expression in hHPCs. During hepatocellular regeneration, hHPCs from the ductular reactions highly expressed NUMB in end-stage pathology. In contrast, NUMB expression was consistently lost in the ductular reactions during human biliary disease and regeneration; this was reflected in the amounts of NUMB protein within the ductular reactions ( Fig. 3a) . In the mouse models of hepatocellular regeneration, we found a persistence of Numb protein throughout the biliary network and in mHPCs over the 2-week time course we studied (Fig. 3b) . This was confirmed in isolated mHPCs where Numb was highly expressed (Fig. 3b) . Induction of biliary regeneration resulted in a rapid loss of Numb from mHPCs at both the mRNA and protein levels ( Fig. 3b and Supplementary Fig. 3a) .
We used RNAi targeted to Numb in a well-characterized mHPC line, BMOL 37 , which becomes positive for Hnf4a and Numb expression when treated with canonical recombinant human Wnt3a (Fig. 3c) . Here we achieved a significant knockdown of Numb transcript with two sequences targeted to different domains of the Numb mRNA molecule (Numb RNAi1 (Fig. 3d) and Numb RNAi2 (Supplementary Fig. 3b) ) compared with cells transfected with a scrambled RNAi control. Numb knockdown resulted in the activation of Hes1, indicating that the Notch pathway had become activated, as well as in increased Hnf1b and Hnf6 expression conferring biliary specification (Fig. 3d) .
Wnt drives hepatocyte differentiation in vivo
Stabilized CTNNB1 was found within the cytoplasm and nucleus of hHPCs within ductular reactions of HCV-infected liver, whereas in npg PBC and PSC, CTNNB1 was predominantly localized to the cell surface, suggesting low activation of the canonical Wnt signaling pathway (Supplementary Fig. 4a) . We also observed comparable localization of stable Ctnnb1 in our mouse models of hepatocellular and biliary regeneration (Fig. 4a) . We confirmed this variation in Wnt pathway activation by expression analysis of the Wnt targets Axin2, Sox9, Myc and Twist1 (refs. 38,39) , all of which were more highly expressed during hepatocellular rather than biliary regeneration (Fig. 4a) .
We used a transgenic mouse that expresses a tamoxifen-responsive Cre recombinase under the control of the Krt19 promoter (Krt19CreER T ) 40 . We activated the canonical Wnt pathway by stabilizing Ctnnb1 though conditional deletion of exon 3 (Ctnnb1 ∆Ex3 ), making Ctnnb1 resistant to degradation and causing its nuclear accumulation (Fig. 4b) . All mice contained the Krt19-driven CreER T and either a wild-type or ∆Ex3 Ctnnb1 locus. Activation of the Ctnnb1 mutant and the subsequent accumulation of nuclear Ctnnb1 in mHPCs did not result in an increase in the number of Ctnnb1-positive hepatocytes within the liver parenchyma when the mice were healthy (Fig. 4b) , indicating that the Cre line was not nonselectively activated in adult hepatocytes and that activation of the Ctnnb1 mutation did not cause mHPCs to become hepatocytes in the absence of damage (Fig. 4b) . During 2 weeks of biliary damage, there was only a small proportion of hepatocytes (~3%) that showed a high concentration of Ctnnb1 in the nucleus when Ctnnb1 was wild type (Fig. 4b) . Upon tamoxifen administration to Krt19CreER T ; Ctnnb1 ∆Ex3 double transgenic mice, the number of hepatocytes that were positive for nuclear Ctnnb1 increased significantly from ~3% to 12.5% (Fig. 4b) , indicating that during biliary damage ectopic activation of the canonical Wnt pathway through stabilization of Ctnnb1 redirects mHPCs from a cholangiocytic fate to a hepatocellular fate.
Bile ducts form in the absence of hepatic macrophages Our data indicated that Wnt signaling is required for HPC specification into hepatocytes. To address the source of Wnt expression observed during regeneration of hepatocytes, we isolated F4/80-positive macrophages from mice undergoing either biliary or hepatocyte regeneration. Macrophages from mice undergoing hepatocyte regeneration expressed large amounts of Wnt3a (Fig. 5a) ; during biliary regeneration, expression of Wnt3a was lower compared with control mice (Fig. 5a) . The Wnt3a protein could be readily seen as punctuate positivity in mononuclear cells in the activated niche, forming close associations with panCK-positive mHPCs during hepatocyte regeneration (Fig. 5a) . Wnt3a-positive cells were found only very infrequently associated with mHPCs during biliary regeneration, where they were restricted to the inflammatory region outside the myofibroblast niche (Supplementary Fig. 4b ).
Phagocytosis of hepatocytes induces Wnt expression
We exposed mouse bone marrow-derived macrophages to sonicated hepatocyte debris. Phagocytosis of the debris resulted in the upregulation of mRNA for both canonical ligands Wnt3a and Wnt7a (Fig. 5b) ; this phenotype was induced only through the phagocytosis of biological debris and not of synthetic phagocytic substrates (latex beads or liposomes) 41 . In vitro coculture of post-phagocytic macrophages with primary mHPCs (Supplementary Fig. 4c ) resulted in an increased expression of Wnt target genes that were not expressed in the single cultures alone (Supplementary Fig. 4d ). Treatment of these cocultures with the Wnt inhibitor recombinant human WIF1 (rhWIF1) resulted in a significant decrease in the expression of Wnt pathway target mRNAs Axin2, Myc, Sox9 and Twist1. Moreover, treatment of the mHPC-macrophage cocultures with rhWIF1 resulted in the decreased expression of the hepatocyte genes Hnf4a and Hnf1a, while promoting the expression of biliary genes Hnf1b and Hnf6, suggesting that in vitro macrophage-derived Wnt was necessary in the maintenance of hepatocyte phenotype and the suppression of biliary differentiation (Fig. 5c) . In this coculture system, it is possible that activation of the canonical Wnt targets was also occurring in macrophages; however, as macrophages do not express liver-enriched transcription factors (Supplementary Fig. 4e ), we concluded that the canonical Wnt pathway promoted hepatocyte specification within the mHPCs. To confirm this, we decided to remove macrophages during mHPC-mediated regeneration and address whether canonical Wnt targets and the mHPC phenotype are altered in vivo.
We ablated liver macrophages using liposomal clodronate 42 every 3 d during 2 weeks of hepatocellular injury and regeneration, which was confirmed as the loss of pan-macrophage marker F4/80 in cells after clodronate treatment but not in controls (Supplementary Fig. 5a ). Liposomal clodronate did not have off-target affects, and the remainder of the nonparenchymal cells remained intact during regeneration (Supplementary Fig. 5b) . Ablation of macrophages during hepatocyte regeneration resulted in mHPCs forming periportal biliary npg structures with a clear lumen akin to bile ducts, rather than infiltrating the parenchyma to regenerate hepatocytes (Fig. 6a) . There was no nuclear Ctnnb1 seen in mHPCs of macrophage-depleted mice, whereas in controls, Ctnnb1 localized to the mHPC nucleus, implying activation of the canonical Wnt pathway ( Fig. 6a and Supplementary  Fig. 6a ). During macrophage ablation, expression of Wnt pathway targets Axin2, Myc, Sox9 and Twist1 in mHPCs was decreased compared with controls, suggesting that macrophage ablation resulted in a loss of the canonical Wnt signaling to mHPCs (Fig. 6b) . The promoter region of Numb contains TCF and LEF binding sites and may be directly regulated though the canonical Wnt signaling pathway 26 . During macrophage ablation, amounts of Numb transcript fell markedly. Moreover, macrophage ablation during hepatocellular regeneration resulted in loss of hepatocyte transcription factor Hnf4a and Hnf1a mRNA expression, while inducing expression of the Hes1 mRNA, as well as the biliary transcripts Hnf1b and Hnf6, indicating that in the absence of macrophages, mHPCs formed bile ducts as a default lineage pathway, and exit from this fate occurred in a Wntdependent manner (Supplementary Fig. 6b) . Ultimately, ablation of macrophages resulted in an increase in the number of Hnf1b-positive mHPCs (Fig. 6c) and a reduction in the number Hnf4a-positive mHPCs (Fig. 6c) .
DISCUSSION
Here we have described the mechanisms by which HPCs in the adult liver are able to acquire divergent cell fates in response to diverse diseases and how the local cellular microenvironment can be modulated to achieve a defined progenitor specification. Notch signaling has been described in the ontogeny of bile ducts from an equipotent population of fetal hepatoblasts 43 , the abrogation of which results in the biliary malformations seen in Alagilles syndrome 44 . Here we observed that during adult biliary regeneration there was a requirement for an activated Notch signaling pathway to specify biliary epithelium from naive HPCs and that in the mouse there is a reca-pitulation of the portal mesenchyme seen during development 45 . We found Jagged1 ligand in proximity to Notch receptor on the HPCs, which expressed greater amounts of Notch signaling pathway targets Hes and Hey during biliary regeneration. In vitro and in vivo inhibition of Notch signaling, with a reduction in vivo of biliary cell numbers and liver-enriched transcription factors associated with biliary fate 46, 47 , shows that Notch is required for adult biliary specification during chronic liver injury. We described a canonical Wnt-dependent action for the ubiquitin ligase Numb, which is required for the exit of HPCs from a biliary specification and acquisition of a hepatocyte cellular fate. In an mHPC cell line, stimulation with canonical Wnt3a, a ligand implicated in multiple stages of hepatocyte differentiation 48 , drives Numb expression. Moreover, inhibition of Numb facilitates the activation of the Notch signaling, as previously described 49, 50 , and activates a biliary phenotype. This study has identified a new role for the canonical Wnt signaling pathway in mHPC specification to hepatocytes in vivo, where ectopic activation of the Wnt pathway commits mHPCs to a hepatocyte fate (summarized in Supplementary Fig. 7) . Of note, these data show that interactions between pathways are essential for correct HPC specification. Other signaling pathways may also be implicated in HPC specification. Expression of Sox9, an mHPC marker 3, 28 , is regulated by both canonical Wnt signaling and Hedgehog signaling 51 , the latter also acting as a modifier of the canonical Wnt pathway 52 . Hedgehog signaling has also been extensively implicated in the phenotype of Alagilles syndrome and has a major role in biliary remodeling 53, 54 , indicating that there may be a node at which the Hedgehog-Wnt-Notch pathways could interact to regulate the relationship between HPC proliferation and fate 55 .
The inflammatory stroma has been insufficiently studied as a component of the hepatic regenerative response; however, the pathological analysis of other organs implicates this as a key component of regeneration. In kidney regeneration, macrophage-derived Wnt7b is required for renal tubular epithelial regeneration 7, 56 . In liver disease, npg the hepatic immune component has been shown to play a vital role in the survival and maintenance of hepatocytes 57,58 . Here we have described how hepatic macrophages have a role in HPC-mediated regeneration of hepatocytes, where Wnt3a is expressed by macrophages as a result of the phagocytosis of biological debris, implicating macrophages in environmental sensing and correct epithelial repair from HPCs 59 . Mice that lack macrophages in vivo do not specify hepatocytes from mHPCs. Their mHPCs upregulate biliary genes, do not migrate and form aberrant tubules, akin to regeneration during biliary disease 60 . In severe liver disease, marked ductular reactions and failure of adequate hepatocyte regeneration is often seen. Understanding the biology of this process may provide a therapeutic target for stimulating more proper regeneration.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
